Tracking U.S. COVID-19 Vaccine Donations
This analysis assesses U.S. COVID-19 vaccine dose donations in order to gauge progress towards meeting stated global vaccination goals.
The independent source for health policy research, polling, and news.
KFF’s policy research provides facts and analysis on a wide range of policy issues and public programs.
KFF designs, conducts and analyzes original public opinion and survey research on Americans’ attitudes, knowledge, and experiences with the health care system to help amplify the public’s voice in major national debates.
KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the organization’s core operating programs.
This analysis assesses U.S. COVID-19 vaccine dose donations in order to gauge progress towards meeting stated global vaccination goals.
This analysis examines overall COVID-19 vaccination levels and how the rate of vaccinations over the last week has changed at state-level and national level. There is significant variability by state in how many adults in the US have been vaccinated with at least one dose. Most states are also seeing a decline in the pace of vaccinations, indicating that they may be approaching the point when vaccine supply exceeds demand.
While some have praised the most recent U.S. donation announcement as an important development, others have said the U.S. could do much more, pointing to the large supply of doses the U.S. is building up and the slowing demand for vaccinations in the country. In this policy watch, we sought to put the U.S. pledge of 80 million doses in further context.
In his latest Axios column, Drew Altman looks at the challenge of vaccine hesitancy in rural America and its implications. One of them: a highly tailored outreach campaign is needed. “Addressing this hesitancy will require convincing rural Americans about the seriousness of the pandemic, and then that the vaccine is a way to protect them, their families and their way of life,” he said.
Based on data from the KFF COVID-19 Vaccine Monitor, this poll finding explores attitudes among Hispanic Americans toward the coronavirus and a generational gap in willingness to get a potential vaccine.
Long-term care facility (LTCF) cases and deaths were highest in the final two months of 2020 in many states, mirroring the spike in total COVID-19 case numbers and deaths this winter.
This brief reviews why racial diversity within COVID-19 vaccine clinical trials is important, discusses the barriers to participation in clinical trials among people of color, and examines the racial/ethnic composition of clinical trial participants for the Pfizer-BioNTech and Moderna vaccines.
During the 52nd week since the first coronavirus case appeared in the United States, the U.S. surpassed 24.6 million total cases and 410,100 deaths due to the pandemic. Here’s our recap of the past week in the coronavirus pandemic from our tracking, policy analysis, polling, and journalism.
Drew Altman’s Axios column draws on data from the new KFF COVID-19 Vaccine Monitor to assess where the country stands on vaccine hesitancy.
Drawing on KFF's poll findings, this interactive dashboard tracks the public’s trusted sources for health information, attitudes toward vaccines, and use of news, social media, and AI for health-related information. It provides visual representations of the key trends in the public’s trust in health information and tracks exposure to and belief in false and unproven health claims.
© 2026 KFF